Cargando…

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know

IN BRIEF Titratable fixed-ratio combinations (FRCs) of a basal insulin and a glucagon-like peptide-1 (GLP-1) receptor agonist are new therapeutic options for people with type 2 diabetes. Two FRCs—insulin degludec/liraglutide and insulin glargine/lixisenatide—have been approved for use in the United...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skolnik, Neil, Hinnen, Debbie, Kiriakov, Yan, Magwire, Melissa L., White, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Feature Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898172/ https://www.ncbi.nlm.nih.gov/pubmed/29686457 http://dx.doi.org/10.2337/cd17-0048

Ejemplares similares

iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes
por: Hinnen, Debbie, et al.
Publicado: (2018)

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
por: Hinnen, Deborah
Publicado: (2017)

Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin
por: Hinnen, Debbie A.
Publicado: (2015)

How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
por: Triplitt, Curtis, et al.
Publicado: (2017)

Everything You Always Wanted to Know about Sexes
por: Whitfield, John
Publicado: (2004)

Titratable fixed‐ratio combination of basal insulin plus a glucagon‐like peptide‐1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes
por: Gomez‐Peralta, Fernando, et al.
Publicado: (2021)

Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes
por: Nomoto, Hiroshi
Publicado: (2023)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
por: Shaefer, Charles F.
Publicado: (2016)

Teacher, Know Thyself
por: Round, Jennifer E.
Publicado: (2012)

The Injection Technique Factor: What You Don’t Know or Teach Can Make a Difference
por: Hirsch, Laurence J., et al.
Publicado: (2019)

Direct comparison two fixed-ratio combination glucagon-like peptide receptor agonist and basal insulin on glycemic and non glycemic parameters in type 2 diabetes
por: Risovic, Ivona, et al.
Publicado: (2023)

You are not alone
por: Elnaqa, Farah
Publicado: (2020)

Insulin Initiation and Titration in Patients With Type 2 Diabetes
por: Chun, Ji, et al.
Publicado: (2019)

How are you coping?
Publicado: (2020)

Successful Resolution of Glucose Toxicity With the Use of Fixed-Ratio Combination Injection of Basal Insulin and Short-Acting Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist
por: Miura, Hiroshi, et al.
Publicado: (2022)

Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?
por: Aroda, Vanita R., et al.
Publicado: (2018)

The right not to know and the obligation to know
por: Davies, Ben
Publicado: (2020)

What doesn't kill you… ?
por: Lawton, Graham
Publicado: (2021)

Basal Cell Carcinoma: What You Need to Know
Publicado: (2015)

Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes
por: Valentine, Virginia, et al.
Publicado: (2015)

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study
por: Polonsky, William, et al.
Publicado: (2021)

Accidents on the rise - are you prepared for the unexpected?
Publicado: (2022)

Basal insulin titration by the app
por: Vangoitsenhoven, Roman, et al.
Publicado: (2023)

Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
por: Wysham, Carol H., et al.
Publicado: (2018)

BDA Benevolent Fund is here to support YOU
por: Keeton, Ros
Publicado: (2022)

Use of Glucagon in Patients With Type 1 Diabetes
por: Haymond, Morey W., et al.
Publicado: (2019)

What to do if you receive a negligence claim
por: Barnes, Greta
Publicado: (2021)

Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes—So Why Is Their Uptake So Low?
por: King, Aaron, et al.
Publicado: (2023)

Remington Honor Medal Address: The Patients (The People) You Touch
por: Grabenstein, John D.
Publicado: (2020)

Lung- and Diaphragm-Protective Ventilation by Titrating Inspiratory Support to Diaphragm Effort: A Randomized Clinical Trial
por: de Vries, Heder J., et al.
Publicado: (2022)

COVID-19: What to do if you're worried about a child
por: Foster, Mark
Publicado: (2020)

Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
por: Valentine, Virginia, et al.
Publicado: (2017)

“Won’t You Be My Doctor?”: Four Keys to a Satisfying Relationship in an Increasingly Virtual World
por: Frankel, Richard M, et al.
Publicado: (2020)

How Effective Is the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) in Different Patient Populations, and When Should It Be Used in Clinical Practice?
por: Tibaldi, Joseph, et al.
Publicado: (2020)

Wants to Know You Know
Publicado: (1885)

Want to Know, You Know
por: Kraft, Frank
Publicado: (1890)

Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)
por: Edelman, Steven, et al.
Publicado: (2023)

How you can get involved in community projects to improve access to dental care and meet the needs of your local population
por: Dodhia, Serena
Publicado: (2022)

Severe Hypoglycemia and the Use of Glucagon Rescue Agents: An Observational Survey in Adults With Type 1 Diabetes
por: Hughes, Allyson S., et al.
Publicado: (2023)

Basal ganglia for beginners: the basic concepts you need to know and their role in movement control
por: Rocha, Gabriel S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9klcaa0ufu21cuvd0t7o6jeq9m